Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Pyelonephritis, Xanthogranulomatous

fluorodeoxyglucose f18 has been researched along with Pyelonephritis, Xanthogranulomatous in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Liu, Y; Tong, G; Wen, Z1
Alavi, A; Cheng, G; Torigian, DA1
Baumgarten, DA; Schuster, DM; Swingle, CA1

Other Studies

3 other study(ies) available for fluorodeoxyglucose f18 and Pyelonephritis, Xanthogranulomatous

ArticleYear
Focal Xanthogranulomatous Pyelonephritis on FDG PET/CT.
    Clinical nuclear medicine, 2022, Sep-01, Volume: 47, Issue:9

    Topics: Aged; Carcinoma, Renal Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Positron Emission Tomography Computed Tomography; Pyelonephritis, Xanthogranulomatous

2022
FDG PET/CT and MRI findings in a patient with focal xanthogranulomatous pyelonephritis mimicking cystic renal malignancy.
    Clinical nephrology, 2011, Volume: 76, Issue:6

    Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Kidney Diseases, Cystic; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Pyelonephritis, Xanthogranulomatous; Radiopharmaceuticals; Tomography, X-Ray Computed

2011
Xanthogranulomatous pyelonephritis characterized on PET/CT.
    Clinical nuclear medicine, 2005, Volume: 30, Issue:11

    Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Pyelonephritis, Xanthogranulomatous; Radiopharmaceuticals; Tomography, X-Ray Computed

2005